Want to see HK:1255 full AI Analyst Report?
1255 Stock Chart & Stats
HK$2.02
-HK$0.22(-9.09%)
At close: 4:00 PM EDT
HK$2.02
-HK$0.22(-9.09%)
Day’s Range― - ―
52-Week RangeHK$0.30 - HK$3.79
Previous CloseN/A
Volume184.00K
Average Volume (3M)9.73K
Market Cap
HK$485.69M
Enterprise ValueHK$871.12
Total Cash (Recent Filing)HK$10.43M
Total Debt (Recent Filing)HK$32.63M
Price to Earnings (P/E)―
Beta0.27
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.34%
Share Statistics
EPS (TTM)-0.03
Shares Outstanding242,845,000
10 Day Avg. Volume10,400
30 Day Avg. Volume9,733
Financial Highlights & Ratios
PEG Ratio-0.20
Price to Book (P/B)-5.80
Price to Sales (P/S)3.16
P/FCF Ratio-14.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundThe return to revenue growth and a partial rebound in 2025 indicate that demand and commercial activity can recover after the prior contraction. If this improvement persists, it could rebuild scale, support operating leverage, and strengthen the company’s ability to fund its business.
Strong Gross MarginAn approximately 80% gross margin provides meaningful economic value on each unit of revenue and creates room to absorb operating costs. Sustaining this margin would give the company a stronger foundation for improving profitability if revenue growth and cost discipline continue.
Debt ReductionDebt reduction from the 2020 peak is a constructive balance-sheet development that can reduce future financing pressure and interest burdens. Although leverage remains a concern, lower absolute debt may provide more flexibility if operating performance and cash conversion improve.
Bears Say
Negative Shareholders’ EquityNegative shareholders’ equity signals a severely weakened capital base and limits financial flexibility. It also makes debt-to-equity measures distorted, while leaving fewer internal resources to absorb operating setbacks, support investment, or withstand further losses over the coming periods.
Cash BurnNegative operating and free cash flow in the latest year indicates that reported earnings are not translating reliably into cash. Persistent cash burn could increase funding pressure, constrain reinvestment, and make the business more vulnerable if working-capital needs or weak profitability continue.
Unstable ProfitabilityThe repeated swings between substantial losses and profit show that earnings are not yet consistent or clearly driven by core operations. Weak EBIT and EBITDA performance in most years reduces confidence that the 2025 improvement can become a durable earnings base.
TATA Health International Holdings Ltd. News
1255 FAQ
What was TATA Health International Holdings Ltd.’s price range in the past 12 months?
TATA Health International Holdings Ltd. lowest stock price was HK$0.30 and its highest was HK$3.79 in the past 12 months.
What is TATA Health International Holdings Ltd.’s market cap?
TATA Health International Holdings Ltd.’s market cap is HK$485.69M.
When is TATA Health International Holdings Ltd.’s upcoming earnings report date?
TATA Health International Holdings Ltd.’s upcoming earnings report date is Apr 01, 2027 which is in 181 days.
How were TATA Health International Holdings Ltd.’s earnings last quarter?
TATA Health International Holdings Ltd. released its earnings results on Aug 28, 2026. The company reported -HK$0.001 earnings per share for the quarter.
Is TATA Health International Holdings Ltd. overvalued?
According to Wall Street analysts TATA Health International Holdings Ltd.’s price is currently Overvalued.
Does TATA Health International Holdings Ltd. pay dividends?
TATA Health International Holdings Ltd. pays a Notavailable dividend of HK$0.023 which represents an annual dividend yield of 4.34%. See more information on TATA Health International Holdings Ltd. dividends here
What is TATA Health International Holdings Ltd.’s EPS estimate?
TATA Health International Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TATA Health International Holdings Ltd. have?
TATA Health International Holdings Ltd. has 242,845,000 shares outstanding.
What happened to TATA Health International Holdings Ltd.’s price movement after its last earnings report?
TATA Health International Holdings Ltd. reported an EPS of -HK$0.001 in its last earnings report. Following the earnings report the stock price went up 0.249%.
Which hedge fund is a major shareholder of TATA Health International Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:1255
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
TATA Health International Holdings Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-20.66%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
TATA Health International Holdings Ltd.
TATA Health International Holdings Limited functions as an investment holding company with diverse business interests, including the sale of footwear and healthcare goods, in addition to offering financial and online medical services. Its operations are structured into distinct segments: Footwear Products Trading, Healthcare Products Trading, Financial Services, and Online Medical Services. The company engages in both wholesale and retail distribution of footwear, featuring prominent brands like Clarks and Josef Seibel. By December 31, 2021, its retail footprint included 29 stores in Hong Kong and one in Macau. Furthermore, its financial services division provides expertise in securities advisory, investment management, and corporate finance consultancy. The company maintains a geographical presence across Hong Kong, Australia, Macau, and Mainland China. Founded in 1974 and headquartered in Kwai Chung, Hong Kong, the firm rebranded from S. Culture International Holdings Limited to its current name in November 2020.
Technical Analysis
Daphne International Holdings
―
Stella International Holdings Limited
―
361 Degrees International
―
Yue Yuen Industrial (Holdings)
―
C.banner International Holdings Ltd.
―